Panayiotis P. Constantinides researcher
Constantinides, Panayiotis Pericleous, 1953-
VIAF ID: 60578012 (Personal)
Permalink: http://viaf.org/viaf/60578012
Preferred Forms
Works
Title | Sources |
---|---|
Advances in the use of tocols as drug delivery vehicles | |
Carboxylesterases 1 and 2 hydrolyze phospho-nonsteroidal anti-inflammatory drugs: relevance to their pharmacological activity | |
Considerations and recommendations on traditional and non-traditional uses of excipients in oral drug products | |
In vitro and in vivo metabolic studies of phospho-aspirin (MDC-22) | |
Inhibition of intestinal absorption of cholesterol by surface-modified nanostructured aluminosilicate compounds | |
Interaction of Adriamycin with Single and Multibilayer Dipalmitoylphosphatidylcholine Vesicles: Spin-Labeling and Calorimetric Study | |
Lipid-based systems for the enhanced delivery of poorly water soluble drugs | |
Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: in vitro/in vivo case studies | |
Nanodelivery strategies in cancer chemotherapy: biological rationale and pharmaceutical perspectives | |
Pegylation improves the pharmacokinetics and bioavailability of small-molecule drugs hydrolyzable by esterases: a study of phospho-Ibuprofen | |
Phospho-sulindac (OXT-328) inhibits the growth of human lung cancer xenografts in mice: enhanced efficacy and mitochondria targeting by its formulation in solid lipid nanoparticles | |
Phosphosulindac (OXT-328) selectively targets breast cancer stem cells in vitro and in human breast cancer xenografts | |
Physical properties of long chain ... 1983 | |
Protonated nanostructured aluminosilicate (NSAS) reduces plasma cholesterol concentrations and atherosclerotic lesions in Apolipoprotein E deficient mice fed a high cholesterol and high fat diet | |
Regioselective oxidation of phospho-NSAIDs by human cytochrome P450 and flavin monooxygenase isoforms: implications for their pharmacokinetic properties and safety | |
Research and development in drug innovation: reflections from the 2013 bioeconomy conference in China, lessons learned and future perspectives | |
Sterically stabilized liposomes incorporating the novel anticancer agent phospho-ibuprofen (MDC-917): preparation, characterization, and in vitro/in vivo evaluation | |
Targeting mitochondrial STAT3 with the novel phospho-valproic acid (MDC-1112) inhibits pancreatic cancer growth in mice | |
Tocol emulsions for drug solubilization and parenteral delivery | |
Topical phospho-sulindac (OXT-328) is effective in the treatment of non-melanoma skin cancer |